The initial public offering price range for Molbio Diagnostics has been established, with a target of raising ₹940 crore. Subscription will begin on August 10, featuring a combination of fresh share issuance and offer for sale. Leading this endeavor are Kotak Mahindra Capital and IIFL Capital Services, assisted by Jefferies India and Motilal Oswal as book-running lead managers.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.